Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal Cancer-Reference-Cited by-同舟云学术

Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal Cancer

Published:2017-07-04 Issue:12 Volume:109 Page:
ISSN:0027-8874
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Fokas Emmanouil¹²³,Ströbel Philipp⁴,Fietkau Rainer⁵,Ghadimi Michael⁶,Liersch Torsten⁶,Grabenbauer Gerhard G⁷,Hartmann Arndt⁸,Kaufmann Marco⁹,Sauer Rolf⁵,Graeven Ullrich¹⁰,Hoffmanns Hans¹¹,Raab Hans-Rudolf¹²,Hothorn Torsten⁹,Wittekind Christian¹³,Rödel Claus¹²³,

Affiliation:

1. Department of Radiotherapy and Oncology, University of Frankfurt, Frankfurt, Germany

2. German Cancer Research Center (DKFZ), Heidelberg, Germany

3. German Cancer Consortium (DKTK), partner site: Frankfurt/Mainz, Heidelberg, Germany

4. Institute of Pathology, University Medical Center Göttingen, Göttingen, Germany

5. Department of Radiation Therapy, University of Erlangen-Nürnberg, Nürnberg, Germany

6. Department of General, Visceral and Pediatric Surgery, University Medical Center Göttingen, Göttingen, Germany

7. Department of Radiation Oncology and Radiotherapy, DiaCura and Klinikum Coburg, Coburg, Germany

8. Institute of Pathology

9. Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland

10. Department of Hematology/Oncology and Gastroenterology, Kliniken Maria Hilf GmbH Mönchengladbach, Mönchengladbach, Germany

11. Department of Radiation Oncology, Kliniken Maria Hilf GmbH Mönchengladbach, Mönchengladbach, Germany

12. Department of General and Visceral Surgery, University of Oldenburg, Oldenburg, Germany

13. Institute of Pathology, University of Leipzig, Leipzig, Germany

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/109/12/djx095/23708860/djx095.pdf

Reference30 articles.

1. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer;Kapiteijn;N Engl J Med.,2001

2. Preoperative vs postoperative chemoradiotherapy for rectal cancer;Sauer;N Engl J Med.,2004

3. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial;van Gijn;Lancet Oncol.,2011

4. Preoperative vs postoperative chemoradiotherapy for locally advanced rectal cancer: Results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow up of 11 years;Sauer;J Clin Oncol.,2012

5. Advances and challenges in treatment of locally advanced rectal cancer;Smith;J Clin Oncol.,2015

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant Chemotherapy With Oxaliplatin and Fluoropyrimidine Versus Upfront Surgery for Locally Advanced Colon Cancer: The Randomized, Phase III OPTICAL Trial;Journal of Clinical Oncology;2024-09-01

2. Prognostic analysis of rectal cancer patients after neoadjuvant chemoradiotherapy: different prognostic factors in patients with different TRGs;International Journal of Colorectal Disease;2024-06-19

3. Best practices and recommendations for grossing and reporting of post-immunotherapy nephrectomy specimens: a single-institution experience of 70 cases;Diagnostic Histopathology;2024-05

4. The clinical relevance of adjuvant chemotherapy in locally advanced rectal cancer patients achieving near pathological complete response following neoadjuvant chemoradiotherapy: Insights from ypT stage;European Journal of Surgical Oncology;2024-04

5. Predictive effect of the systemic inflammation response index (SIRI) on the efficacy and prognosis of neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer;BMC Surgery;2024-03-13